Amwell (NYSE: AMWL) reported Q1 EPS of ($1.42), which may not compare to the analyst estimate of ($0.21). Revenue for the quarter came in at $64 million versus the consensus estimate of $65.08 million.

GUIDANCE:

Amwell sees FY2023 revenue of $275-285 million, versus the consensus of $278.19 million.

For earnings history and earnings-related data on Amwell (AMWL) click here.